Showing results (11-20 of 295) with videos related to
Sort By:
Pageof 30
Science (New York, N.Y.)|January 28, 2006
Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndromePablo Rodriguez-Viciana, Osamu Tetsu, William E Tidyman, et al.Journal of Molecular Medicine (Berlin, Germany)|March 11, 2016
K-Ras protein as a drug targetFrank McCormickCancer Biology & Therapy|September 26, 2003
Cancer-specific viruses and the development of ONYX-015Frank McCormickCancer Cell|January 18, 2020
Sticking it to KRAS: Covalent Inhibitors Enter the ClinicFrank McCormickBiological Chemistry|April 4, 2026
The heart of the matter: a personal view of Fred Wittinghofer's contributions to RAS biology and drug designFrank McCormickExpert Opinion on Therapeutic Targets|January 7, 2015
The potential of targeting Ras proteins in lung cancerFrank McCormickAdvances in Cancer Research|February 1, 2022
A brief history of RAS and the RAS InitiativeFrank McCormickJournal of Surgical Oncology|April 12, 2011
Cancer therapy based on oncogene addictionFrank McCormickCurrent Opinion in Genetics & Development|January 18, 2011
Mutant onco-proteins as drug targets: successes, failures, and future prospectsFrank McCormickPageof 30